Raia Drogasil S.A.
RADL3
Rank in Stocks
#2648
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal... Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.
Share Price
$4.10
Last synced: 2026-10-19
Market Cap
$7.18B
Change (1 day)
4.09%
Change (1 year)
13.29%
Country
BR
Trade Raia Drogasil S.A. (RADL3)
Category
Consumer Defensive
Earnings for Raia Drogasil S.A. (RADL3)
Earnings in Jun 2026 TTM: $288.64M
According to Raia Drogasil S.A. latest financial reports the company's current earnings are $288.64M. In 2023 the company made an earning of $250.74M, an increase over its 2022 earnings that were of $225.70M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Raia Drogasil S.A. from 2003 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $288.64M | 25.99% |
| 2024 | $229.10M | -8.63% |
| 2023 | $250.74M | 11.09% |
| 2022 | $225.70M | 27.37% |
| 2021 | $177.20M | 49.32% |
| 2020 | $118.68M | -39.16% |
| 2019 | $195.07M | 18.52% |
| 2018 | $164.59M | -20.60% |
| 2017 | $207.30M | 13.31% |
| 2016 | $182.95M | 65.89% |
| 2015 | $110.28M | -2.84% |
| 2014 | $113.50M | 92.24% |
| 2013 | $59.04M | -23.49% |
| 2012 | $77.16M | 57.81% |
| 2011 | $48.90M | -32.82% |
| 2010 | $72.78M | 20.53% |
| 2009 | $60.39M | 100.99% |
| 2008 | $30.05M | 71.58% |
| 2007 | $17.51M | 33.62% |
| 2006 | $13.10M | 131.37% |
| 2005 | $5.66M | 42.39% |
| 2004 | $3.98M | 20.41% |
| 2003 | $3.30M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $20.38B | 6,959.56% |
US
|
|
| $9.83B | 3,304.31% |
FR
|
|
| $2.94B | 918.90% |
US
|
|
| $1.55B | 436.99% |
IN
|
|
| $517.00M | 79.11% |
US
|
